Thirty-three percent of new patients who underwent a sleep study that resulted in OSA were women. It’s not surprising, of course, that women should suffer the same pains as men when it comes to sleep. However, diagnosis in women is usually harder to come by and sometimes overlooked. Why? There are a few reasons. First is the stereotype. Doctors too are often mislead by the stereotype and will not consider OSA as a possible reason for a woman’s tiredness or reduction in quality of life. Second, women tend to snore less often than men. Read the rest of this entry
Sleep apnea is a deadly disorder that occurs when a person’s breathing is interrupted during sleep. People with untreated sleep apnea stop breathing repeatedly during their sleep, sometimes hundreds of times.
The home sleep apnea testing started in the month of January. Till the availability of home based sleep apnea testing only the sleep centers at Cameron Hospital in Angola, DeKalb Health in Auburn, Parkview Noble Hospital in Kendallville and Parkview LaGrange Hospital in LaGrange used to offer such tests. Sleep testing at a sleep center involved spending the night in the hospital and wearing wires connected to monitors.
Weldon Cline, the Parkview Noble polysomonographer technologist says that some people may be eligible to have these tests done in the comfort of their own homes. Read the rest of this entry
Findings of a research study conducted in Spain attempted assessment OSA and the effectiveness of CPAP treatment in cardiovascular mortality in the elderly and revealed that the younger patients, elderly patients with severe, untreated sleep apnea have a higher cardiovascular mortality than those with mild to moderate disease or those without sleep apnea.
The research also revealed that treatment with CPAP can reduce cardiovascular mortality in elderly OSA patients to levels similar to those found in patients without disease or with mild to moderate sleep apnea. Read the rest of this entry
SleepApneaDisorder/[Press Release]/Asheville, NC /Obstructive Sleep Apnea (OSA) is a common sleep disorder suffered by millions of Americans, and shockingly 3 of 4 sufferers go undiagnosed. OSA constitutes the blocking of the airflow to the respiratory system for periods of time causing the sufferer loss of sleep and overall health.
When treating OSA the bulk of physicians will recommend continuous positive airway pressure or CPAP to their patients. This is a very effective method of treatment, but not all users are happy about wearing a CPAP mask throughout the night. In fact around half of users give up on CPAP therapy within a month.
A new alternative is Provent sleep therapy. Provent, manufactured by Ventus Medical, uses a “MicroValve” design which creates back pressure during exhalation to keep the airway from closing.
Provent was put to the test by Journal Sleep when they trialed its use with 250 sleep apnea sufferers. The study concluded that Provent therapy reduced the effects OSA noticeably during a three month time period.
For more information on Provent visit their website at http://www.proventtherapy.com/index.php A 30 day trial can also be purchased at http://www.cheapcpapsupplies.com/Provent-30-Day-Supply.html
A recently concluded research published in the journal SLEEP attempted to determine the neurocognitive effects of continuous positive airway pressure (CPAP) therapy on patients with obstructive sleep apnea (OSA).
The Apnea Positive Pressure Long-term Efficacy Study was a 6-month, randomized, double-blind, 2-arm, sham-controlled, multicenter trial conducted at 5 U.S. university, hospital, or private practices. Of 1,516 participants enrolled, 1,105 were randomized, and 1,098 participants diagnosed with OSA contributed to the analysis of the primary outcome measures. Read the rest of this entry
A research concluded recently has revealed its findings that those who are suffering from obstructive sleep apnea (OSA) may control the sleep issue while traveling to higher altitudes if they can combine auto-adjusted continuous positive airway pressure (autoCPAP) with acetazolamide.
“Our study provides important information for patients with OSA planning a stay at altitude because they can continue using their CPAP in auto-adjusting mode during altitude travel and enhance this treatment with acetazolamide if they want to spend less time awake at night, to achieve a higher arterial oxygen saturation and an optimal control of sleep apnea,” said Konrad Bloch, from University Hospital of Zurich in Switzerland. Read the rest of this entry
Building on their highly successful System One humidification, Philips Respironics has introduced an additional humidification solution that enhances performance, flexibility and comfort for the sleep apnea sufferer. The System One Heated Tube provides CPAP users with air temperature control, improved humidification and rainout protection. The Heated Tube can only be found on the Philips Respironics System One REMstar Auto A-Flex with Heated Humidification and Heated Tube model DS560TS.
The System One Heated Tube takes into account the room temperature and humidity by using a sensor at the end of the Heated Tube to allow the CPAP user to choose what temperature is right for them and at the same time protects against rainout. The Heated Tube is a welcome advance in CPAP therapy and is just another reason why Philips Respironics is a leader in the sleep therapy market. Read the rest of this entry
Siesta Medical, Inc., a developer of minimally invasive surgical solutions for obstructive sleep apnea (OSA), announced the U.S. launch of its Encore™ Tongue Suspension System for the treatment of OSA. The Encore™ System simplifies and improves the control of tongue suspension, a procedure shown to be an effective treatment for obstructive sleep apnea (OSA).
Dr. Jason van Tassel at Washington Hospital in Fremont, CA performed one of the first patient implants.
“Through a small incision, the Encore System allowed me to navigate the tongue base and easily place suspension loops. Controlling the final tension and advancement of the tongue base was easy and much simpler than with previous tongue suspension devices. This was a quick and minimally invasive surgery and is a potentially attractive surgical option for OSA patients with tongue base obstructions” said Dr. van Tassel. Read the rest of this entry
Lee A. Surkin, MD is the first medical practice in the state of North Carolina to offer Provent Sleep Apnea Therapy, an innovative, non-invasive treatment for obstructive sleep apnea (OSA) to patients in Greenville and throughout North Carolina. Cleared by the US FDA in 2008, Provent Therapy is a simple and effective new treatment option for obstructive sleep apnea. Provent Therapy utilizes the patient’s own breathing to provide clinically proven results in the treatment of OSA.
CPAP (continuous positive airway pressure) is currently the gold standard for treatment of OSA and is extremely effective at treating OSA when worn as directed. However, up to half of all patients are not compliant with CPAP therapy due to the cumbersome nature of the treatment. Provent Therapy was developed to help patients who cannot tolerate CPAP therapy and may benefit from the small non-invasive and effective technology Provent Therapy provides. Read the rest of this entry
For patients with severe obstructive sleep apnea, three months of continuous positive airway pressure (CPAP) therapy is associated with reduced blood pressure, and partial reversal of metabolic abnormalities, according to a study published in the Dec. 15 issue of the New England Journal of Medicine.
Surendra K. Sharma, M.D., Ph.D., from the All India Institute of Medical Sciences in New Delhi, and colleagues investigated the effects of CPAP treatment on metabolic syndrome in 86 patients with obstructive sleep apnea syndrome. Patients were assigned to real or sham CPAP for three months, followed by a washout period of one month, and then a crossover to the other intervention for three months. Anthropometric variables, blood pressure, fasting blood glucose levels and lipid profile, insulin resistance, glycated hemoglobin levels, carotid intima-media thickness, and visceral fat were measured before and after each intervention. Read the rest of this entry